Nanoparticulate delivery of potent microtubule inhibitor for metastatic melanoma treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nanoparticulate delivery of potent microtubule inhibitor for metastatic melanoma treatment

Published:2019-09 Issue: Volume:309 Page:231-243
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Bariwal Jitender,Kumar Virender,Chen Hao,Bhattarai Rajan Sharma,Peng Yang,Li Wei^ORCID,Mahato Ram I.^ORCID

Funder

UNMC

NCI

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference50 articles.

1. Recent developments in tubulin polymerization inhibitors: an overview;Kaur;Eur. J. Med. Chem.,2014

2. Pharmacokinetic optimization of 4-substituted methoxybenzoyl-aryl-thiazole and 2-aryl-4-benzoyl-imidazole for improving oral bioavailability;Li;Drug Metab. Dispos.,2011

3. A potent, metabolically stable tubulin inhibitor targets the colchicine binding site and overcomes taxane resistance;Arnst;Cancer Res.,2018

4. Structural basis for the regulation of tubulin by vinblastine;Gigant;Nature,2005

5. Variations in the colchicine-binding domain provide insight into the structural switch of tubulin;Dorleans;Proc. Natl. Acad. Sci. U. S. A.,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dietary supplementation with α-ionone alleviates chronic UVB exposure-induced skin photoaging in mice;Food & Function;2024

2. Disulfide Bond-Based SN38 Prodrug Nanoassemblies with High Drug Loading and Reduction-Triggered Drug Release for Pancreatic Cancer Therapy;International Journal of Nanomedicine;2023-03

3. Non-viral gene coating modified IOL delivering PDGFR-α shRNA interferes with the fibrogenic process to prevent posterior capsular opacification;Regenerative Biomaterials;2023-01-01

4. pH-sensitive nanomedicine of novel tubulin polymerization inhibitor for lung metastatic melanoma;Journal of Controlled Release;2022-10

5. Nanoparticle Delivery of Novel PDE4B Inhibitor for the Treatment of Alcoholic Liver Disease;Pharmaceutics;2022-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3